Axxelent Pharma Science Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2019.
2019 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Axxelent Pharma Science Private Limited

Axxelent Pharma Science Private Limited, a active private limited company, was established on 07 October 2019 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110TN2019PTC131943. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹175.00 Cr and a paid-up capital of ₹61.67 Cr.

It upholds a compliant status. Employing 330 professional, Its leadership includes Sreenivasa Reddy Bhimanatham (Whole-Time Director), Swaminathan Ramesh (Cfo), Sampath Kumar Devarajan (Director). Past directors included Vivekanand Parachur, Shankarlal Devendra, Sreenivasa Reddy Bhimanatham. It holds ₹305.96 Cr open charges and no settled loans. Its latest AGM occurred on 23 May 2025, with the balance sheet filed on 31 March 2025. It is based at No. 3 Jagadeeswaran Street, T.Nagar Chennai, Chennai, Tamil Nadu, 600017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110TN2019PTC131943

  • Registration Number

    131943

  • Incorporation Date

    07 October 2019

  • Authorized Capital

    ₹175.00 Cr

  • Paid-Up Capital

    ₹61.67 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 175.00 Cr
  • Paid Up Capital ₹ 61.67 Cr
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 305.96 Cr
  • Revenue Growth **** 237.33%
  • Profit Growth **** 163.89%
  • Ebitda **** 2902.38%
  • Net Worth 434.62%
  • Total Assets **** 29.80%
Company report

Axxelent Pharma Science Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axxelent Pharma Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Axxelent Pharma Science Private Limited?
Current Directors
Name Designation Appointment Date Status
Sreenivasa Reddy Bhimanatham Whole-Time Director 04 Dec 2020 Current
Swaminathan Ramesh Cfo 06 Sep 2025 Current
Sampath Kumar Devarajan Director 07 Oct 2019 Current
Hariharan Subramanian Director 01 Jul 2021 Current
Kamlesh Phulwani Nominee Director 10 Apr 2023 Current
Chaitanya Devandra Whole-Time Director 22 Apr 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 04 Dec 2020 Past
Pramod Abcsdd Director 03 May 2021 Past
Pramod Abcsdd Whole-Time Director 03 Dec 2025 Past
Pramod Abcsdd Additional Director 06 Sep 2021 Past
Pramod Abcsdd Cfo 05 Sep 2025 Past
Pramod Abcsdd Managing Director 22 Apr 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axxelent Pharma Science.

Axxelent Pharma Science Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 237.33% increase. The company also saw a substantial improvement in profitability, with a 163.89% increase in profit. The company's net worth Soared by an impressive increase of 434.62%.

Axxelent Pharma Science revenue growth over time
Axxelent Pharma Science profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 237.33%
*******
*******
*******
*******
Revenue from Operations
*******
 245.44%
*******
*******
*******
*******
Total Assets
*******
 29.80%
*******
*******
*******
*******
Profit or Loss
*******
 163.89%
*******
*******
*******
*******
Net Worth
*******
 434.62%
*******
*******
*******
*******
EBITDA
*******
 2902.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axxelent Pharma Science?

In 2025, Axxelent Pharma Science had a promoter holding of 26.78% and a public holding of 73.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,059,577,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 175.96 Cr
  • Others : 130.00 Cr
Latest Charge Details
Date Lender Amount Status
07 Jul 2025 Others ₹100.00 Cr Open
07 Jul 2025 Others ₹30.00 Cr Open
13 Dec 2023 Hdfc Bank Limited ₹2.46 M Open
30 Sep 2020 Hdfc Bank Limited ₹175.71 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Axxelent Pharma Science?

Axxelent Pharma Science has a workforce of 330 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axxelent Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axxelent Pharma Science's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axxelent Pharma Science
Recent Activity within the Organization
  • Director Appointment

    Ramesh was appointed as a Cfo was appointed as a Cfo on 17 Sep 2025 & has been associated with this company since 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Swaminathan Ramesh was appointed as a CFO was appointed as a CFO on 06 Sep 2025 & has been associated with this company since 5 months 11 days . was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101132515 was registered on 07 Jul 2025. was completed.

  • Charges

    A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101132490 was registered on 07 Jul 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Axxelent Pharma Science Private Limited last Annual general meeting of members was held on 23 May 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Axxelent Pharma Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axxelent Pharma Science Private Limited?

The CIN of Axxelent Pharma Science Private Limited is U24110TN2019PTC131943.

Where is Axxelent Pharma Science Private Limited headquartered?

Axxelent Pharma Science Private Limited is headquartered at No. 3 Jagadeeswaran Street, T.Nagar Chennai, Chennai, Tamil Nadu, 600017.

When was Axxelent Pharma Science Private Limited incorporated?

Axxelent Pharma Science Private Limited was incorporated on 07 October 2019.

Who are the current directors of Axxelent Pharma Science Private Limited?

The current directors of Axxelent Pharma Science Private Limited are

What is the primary industry of Axxelent Pharma Science Private Limited?

The primary industry of Axxelent Pharma Science Private Limited is Manufacturing.

Is Axxelent Pharma Science Private Limited a listed company?

Axxelent Pharma Science Private Limited is unlisted.

What is the capital structure of Axxelent Pharma Science Private Limited?

The authorized capital of Axxelent Pharma Science Private Limited is ₹175.00 Cr, and the paid-up capital is ₹61.67 Cr.

What is the compliance status of Axxelent Pharma Science Private Limited?

The compliance status of Axxelent Pharma Science Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available